Edentulous in the molar area of the mandible.
Conditions
Interventions
Intervention 1: Intervention group: For the first intervention group, 1.8 ml of 2% lidocaine from Pakhsh Daru Company (made in Iran) was administered once during surgery by injection into the surgical
Sponsors
Gorgan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients requiring implant treatment due to loss of bilateral mandibular molar teeth; patients with systemic conditions ASA class I and II; patients aged 18 to 65 years; implant site healing and no need for bone reconstruction; at least 3 months after extraction treatment; no lucency or unusual opacity on radiography; informed consent to participate in the project.
Exclusion criteria
Exclusion criteria: Prohibition of the use of epinephrine with a preservative; use of narcotics, sedatives, NSAIDs, psychotropic drugs and anything that changes the patient's perception of pain; poor pulp health of adjacent teeth; performing implant surgery as a fresh socket; presence of neurological orofacial symptoms; presence of infection in the surgical area; pregnant and lactating women; presence of severe heart disease; dissatisfaction to participate in the study or withdrawal from it.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity score. Timepoint: During soft tissue cutting. Method of measurement: Visual Analog Scale (VAS).;Pain intensity score. Timepoint: In the bone drilling stage. Method of measurement: Visual Analog Scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain intensity score. Timepoint: 1 and 4 hours after surgery. Method of measurement: Visual Analog Scale (VAS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactErmiya Asghari
Gorgan University of Medical Sciences
Outcome results
None listed